Tools to study and target the Siglec–sialic acid axis in cancer-Reference-Cited by-同舟云学术

Tools to study and target the Siglec–sialic acid axis in cancer

Published:2020-12-21 Issue:21 Volume:288 Page:6206-6225
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Läubli Heinz¹,Kawanishi Kunio²,George Vazhappilly Cijo³,Matar Rachel³,Merheb Maxime³,Sarwar Siddiqui Shoib³^ORCID

Affiliation:

1. Laboratory for Cancer Immunotherapy Department of Biomedicine, and Medical Oncology Department of Internal Medicine University Hospital Basel Switzerland

2. Kidney and Vascular Pathology University of Tsukuba Ibaraki Japan

3. Department of Biotechnology American University of Ras Al Khaimah (AURAK) UAE

Funder

American University

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15647

Reference163 articles.

1. Glycosylation in cancer: mechanisms and clinical implications

2. Glycans in immune recognition and response

3. Tumor-Associated Carbohydrate Antigens

4. Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of SIGLEC12 expression, immunomodulation and prognostic value in renal cancer using multiomic databases;Heliyon;2024-01

2. SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity;International Journal of Molecular Sciences;2023-12-05

3. Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages;Biomaterials Advances;2023-11

4. Roles of the Siglec family in bone and bone homeostasis;Biomedicine & Pharmacotherapy;2023-09

5. CD24 blockade as a novel strategy for cancer treatment;International Immunopharmacology;2023-08